Header Logo

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers (Basel). 2018 May 17; 10(5).

View in: PubMed